CCR5 and infection: A small population of individuals are resistant to HIV-1 infection and were found to be homozygous for a naturally occurring 32 bp deletion (CCR5 Δ32) mutation that inhibits CCR5 surface expression and confers resistance to infection by HIV-1 (7–9).